Do you want to read an article? Please log in or register.
Biologics in severe asthma: a state-of-the-art review
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Papaioannou O, Christopoulos I, Tsiri P, Sampsonas F, Karkoulias K, Lykouras D, Sotiropoulou V, Theohari E, Papalexatos D, Komninos D, Christopoulos A, Tzouvelekis A
doi: 10.3390/jcm14072174
COMMENTED
Asthma
Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Mobayed H, Al-Nesf M, Ibrahim T, Aqel S, Al-Ahmad M, Bousquet J
doi: 10.2147/JAA.S517784
RECOMMENDED
AsthmaRespiratory Tract Infection
Efficacy Assessment of Biological Treatments in Severe Asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Laorden D, Domínguez-Ortega J, Romero D, Villamañán E, Mariscal-Aguilar P, Granda P, Quirce S, Álvarez-Sala R, On Behalf Of Asmagrave-Hulp Group
doi: 10.3390/jcm14020321
COMMENTED
Asthma
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
J Clin Med
D'Amato M, Pastore D, Lupia C, Candia C, Bruni A, Garofalo E, Longhini F, Maglio A, Petrone A, Vatrella A, Pelaia G, Pelaia C
doi: 10.3390/jcm14134749
Asthma
Real-World Effectiveness and Safety of Mepolizumab in Severe Eosinophilic Asthma: Insights From the Korean Severe Asthma Registry (KoSAR)
Allergy Asthma Immunol Res
Park SY, Lee D, Kim JH, Lee Y, Ban GY, Sim DW, Kwon JW, Kim SR, Song WJ, Park HW, Chang YS, Koh YI, Lee BJ, Park HS, Cho YS, Kim SH
doi: 10.4168/aair.2025.17.3.384
AsthmaRespiratory Tract Infection
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register
Respir Med
Hansen S, Håkansson KEJ, Soendergaard MB, Bjerrum AS, Schmid JM, Johansson SL, Rasmussen LM, Johnsen CR, von Bülow A, Bonnesen B, Krogh NS, Hilberg O, Dongo L, Vijdea R, Ulrik CS, Porsbjerg C
doi: 10.1016/j.rmed.2025.108203
COMMENTED
Asthma
The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Cosío BG, Iglesias A, Shafiek H, Mosteiro M, Escribano I, Toledo-Pons N, Valera JL, Bellvert CG, Pérez de Llano L
doi: 10.1016/j.chest.2024.11.045
Asthma
Efficacy and Safety of Dupilumab in Children With Moderate-to-Severe Asthma: A Systematic Review of Emerging Phase 3 Evidence
Pediatr Pulmonol
Ghadah A, Aryam A, Shahad A, Hatun A, Amani A, Zinab B, Anoud A, Abdulmajeed A, Tamer A
doi: 10.1002/ppul.71391
COMMENTED
Asthma
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Håkansson KEJ, Hansen S, Soendergaard MB, von Bülow A, Hilberg O, Bonnesen B, Johnsen CR, Lock-Johansson S, Dongo L, Borup MB, Vijdea R, Rasmussen LM, Schmid JM, Ulrik CS, Porsbjerg C, Bjerrum AS
doi: 10.1183/13993003.00926-2025